Manufacturers Life Insurance Company, The Immuneering Corp Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Immuneering Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 82,638 shares of IMRX stock, worth $157,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,638
Previous 82,638
-0.0%
Holding current value
$157,012
Previous $105,000
95.24%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMRX
# of Institutions
43Shares Held
4.66MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.03 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$853,6900.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$467,9130.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $50.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...